Immuneering recently announced positive initial Phase 2a data, including complete and partial responses, with IMM-1-104 in combination with chemotherapy in first-line pancreatic cancer patients ...

Use your computer. The form may not open on tablets or mobile phones. Save the form on your computer in a place you can remember. For most Internet browsers, clicking on the link above will ...

Use your computer. The form may not open on tablets or mobile phones. Save the form on your computer in a place you can remember. For most Internet browsers, clicking on the link above will ...

Biotechnology company that is a leader in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune disease.

This project combine JPDA, IMM(CV,CTRV,CTRA) and UKF to achieve a fast object tracking method.